Likes
None
Company name | Avg Annual Salary | Open Jobs |
---|---|---|
Sun Pharmaceutical Industries Regional Business Manager Salary
10 - 19 years exp. (23 salaries) | ₹12 L/yr - ₹19.5 L/yr
12%
more | |
Cipla Regional Business Manager Salary
11 - 19 years exp. (312 salaries) | ₹8 L/yr - ₹19 L/yr
8%
more | 2 job openings |
Login to view exact salary
| ||
Torrent Pharmaceuticals Regional Business Manager Salary
11 - 23 years exp. (33 salaries) | ₹8.3 L/yr - ₹24.2 L/yr
11%
more | |
Lupin Regional Business Manager Salary
16 - 22 years exp. (5 salaries) | ₹13 L/yr - ₹21.3 L/yr
38%
more | |
Zydus Lifesciences Regional Business Manager Salary
11 - 21 years exp. (128 salaries) | ₹7.5 L/yr - ₹19 L/yr
5%
more | |
Glenmark Pharmaceuticals Regional Business Manager Salary
7 - 15 years exp. (7 salaries) | ₹9.8 L/yr - ₹12 L/yr
20%
less | |
Aurobindo Pharma Regional Business Manager Salary
10 - 16 years exp. (3 salaries) | ₹6.5 L/yr - ₹8.5 L/yr
39%
less | |
Panacea Biotec Regional Business Manager Salary
9 - 21 years exp. (31 salaries) | ₹5.9 L/yr - ₹11.3 L/yr
31%
less | |
Biocon Biologics Regional Business Manager Salary
13 - 21 years exp. (14 salaries) | ₹12 L/yr - ₹19.3 L/yr
16%
more | |
Novozymes South Asia Regional Business Manager Salary
12 - 25 years exp. (8 salaries) | ₹31 L/yr - ₹42 L/yr
163%
more | |
Bharat Biotech International Regional Business Manager Salary
18 - 19 years exp. (3 salaries) | ₹6 L/yr - ₹6.6 L/yr
53%
less | |
Login to view exact salary
| ||
Transasia Bio-Medicals Regional Business Manager Salary
6 - 18 years exp. (3 salaries) | ₹9.3 L/yr - ₹15 L/yr
6%
less | |
Last Updated: 17 Oct 2023
Experience | Avg Annual Salary |
---|---|
12 years (4 salaries) |
₹8.5
L/yr
- ₹18.3
L/yr
|
13 years (4 salaries) |
₹10.9
L/yr
- ₹22.9
L/yr
|
Login to view exact salary
| |
14 years (4 salaries) |
₹8.5
L/yr
- ₹14.7
L/yr
|
15+ years (17 salaries) |
₹9.4
L/yr
- ₹17
L/yr
|
From
To
Regional Business Manager
12 - 20 years exp.
Sales Manager
18 - 27 years exp.
Discover interview dos and don'ts from real experiences
Top trending discussions